longevitywatch
← All podcasts

The Drive

hosted by Peter Attia

We tested 48 claims from The Drive against the research. 14 held up, 4 did not, and the rest are partly true or still too early to judge.

Peter Attia: who he is, what he sells, where he stands →

What a speaker claims elsewhere is on their own profile.

We only test the claims that can be checked, not everything that is said. This is not a ranking.

Peter Attia · hosts The Drive

physician and author specializing in longevity and health · Who he is, what he sells, where he stands →

Partly
“A diet high in saturated fat can raise apoB and LDL cholesterol levels”
Peter Attia (physician and author specializing in longevity and health) · The Drive, November 2026 · watch the episode ↗︎ · stated with caution
That a low-carbohydrate diet, which typically contains a lot of fat, raises LDL cholesterol in most people is well supported by several large reviews of randomised studies. The link with apoB is plausible, because apoB measures the number of harmful lipid particles and is associated with LDL, but our sources do not directly establish that link with a high-fat diet. The claim is therefore correct for LDL, but for apoB specifically, the evidence cannot be derived directly from what is available.
✗ Does not hold up
“An hs-CRP value of 3 mg/l indicates significant inflammation in the body”
Peter Attia (physician and author specializing in longevity and health) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
hs-CRP is precisely used to detect low-grade, chronic inflammation, and a value of 3 mg/l falls into the elevated risk category, not necessarily "significant inflammation". The research describes hs-CRP as a predictor of long-term cardiovascular problems, where even mildly elevated values are clinically relevant. The claim gives the impression that a pronounced inflammatory process is present, but that is not what this measurement reflects: it concerns a smouldering, low-grade inflammation that does not feel acute or intense at all. An acute infection or severe inflammation produces values many times higher.
✓ Holds up
“A long history of smoking can lead to death from COPD”
Peter Attia (physician and author specializing in longevity and health) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
Several large review studies and a fifty-year prospective study involving tens of thousands of male physicians confirm that long-term smoking is the most important risk factor for the development and progression of COPD, and that COPD is associated with considerable mortality. In these studies, smoking is directly linked to death from respiratory diseases. One review describes COPD as claiming the lives of more than three million people worldwide each year, with smoking as the primary cause. The claim that a long history of smoking can lead to death from COPD is thus broadly supported by research in humans.
✓ Holds up
“Chemotherapy often causes serious damage to the blood-forming system.”
Peter Attia (physician and author specializing in longevity and health) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
Multiple studies confirm that damage to the blood-forming system is a common and serious consequence of chemotherapy in humans. A clinical source states that bone marrow suppression is the most common side effect that determines the maximum dose of anticancer drugs, and a separate source on nitrosoureas explicitly names bone marrow suppression as one of the serious side effects of these agents. A study in people with colorectal cancer shows that 40% of patients developed serious blood abnormalities during chemotherapy. Two meta-analyses summarising the results of multiple carefully designed randomised controlled trials treat bone marrow suppression after chemotherapy in lung cancer patients as an established and common clinical problem for which additional treatments are being investigated.
Partly
“Most gains in lifespan come from focusing on overall fitness and health, such as muscle strength, cardiovascular condition and cognitive function, rather than on direct disease prevention.”
Peter Attia (American physician, author and specialist in longevity and preventive medicine) · The Drive, September 2026 · watch the episode ↗︎ · stated with caution
Muscle strength, cardiovascular fitness and cognitive health are indeed associated with a lower risk of premature death and a longer period of healthy living, and the evidence for this is consistent across multiple large studies. However, the claim goes beyond what the research supports: it has not been demonstrated that the majority of longevity gains come from fitness and functional health rather than from disease prevention. That comparison between two strategies has not been made in the literature in that way, and the direction of causality remains unclear in many cases.
✗ Does not hold up
“Interventions that increase the number of years spent in good health simultaneously extend overall lifespan.”
Peter Attia (American physician, author and specialist in longevity and preventive medicine) · The Drive, September 2026 · watch the episode ↗︎ · stated with confidence
Research makes it clear that healthy years and total lifespan are two measurably distinct things that do not automatically go hand in hand. For most interventions, from fasting to supplements, the primary goal is to improve healthspan, not to extend total lifespan. Even caloric restriction, the best-supported approach, has not yet been fully proven in humans to achieve both simultaneously. The claim assumes an automatic link that the evidence does not support.

Navdeep Chandel

Professor of medicine and cell and molecular biology

Partly
“VO2 max declines in adults by about 10 percent per decade”
Navdeep Chandel (Professor of medicine and cell and molecular biology) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
Large meta-analyses summarising the results of many studies do indeed show a decline in VO2 max of about 7 to 11 percent per decade in both men and women, which is close to the stated 10 percent. However, a large-scale longitudinal study in healthy adults shows that the decline is not constant: in one's twenties and thirties it is only 3 to 6 percent per decade, while after the age of seventy it rises to more than 20 percent per decade. The claim of "about 10 percent" is therefore correct as an average across adulthood as a whole, but it misses the nuance that the decline accelerates sharply with age and also differs between men and women. → What is VO2max and how important is it for living longer?
✓ Holds up
“Methylene blue inhibits monoamine oxidases, which means that a high dose can lead to serotonin syndrome in users of serotonin reuptake inhibitors.”
Navdeep Chandel (Professor of medicine and cell and molecular biology) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
Laboratory research shows that methylene blue is a potent inhibitor of the enzyme monoamine oxidase A (and to a lesser extent of the related variant MAO B). This enzyme breaks down certain signalling substances in the brain. Several review studies of documented patient cases confirm that this is the reason why the drug can cause serotonin syndrome in patients taking certain antidepressants: a dangerous accumulation of serotonin in the body. These reviews identify dozens of described cases, most of which occurred with intravenous administration, though oral intake has also been reported. Furthermore, this finding is not limited to high doses: research shows that even relatively low intravenous doses can reach a concentration in the brain that completely blocks the enzyme. The claim that it specifically concerns a "high dose" is therefore somewhat too narrow, but its core, namely that the inhibition of this enzyme is the cause of serotonin syndrome when combined with certain antidepressants, is well supported. → Does methylene blue really work for energy and brain function?
Partly
“Using metformin increases the risk of a vitamin B12 deficiency.”
Navdeep Chandel (Professor of medicine and cell and molecular biology) · The Drive, November 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
Long-term use of metformin does indeed call for attention to vitamin B12 levels; this is stated in so many words in the available information on metformin use without diabetes. That is a different formulation from an increased risk of a full-blown deficiency: the available information points to the need for attention and monitoring, but does not extensively support the stronger claim that metformin actually increases the risk of a deficiency. The direction of the statement is therefore correct, but its firmness goes beyond what the research firmly establishes here.
Partly
“Metformin works considerably better in people with prediabetes than in people with fully developed diabetes.”
Navdeep Chandel (Professor of medicine and cell and molecular biology) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
Metformin is indeed well supported when it comes to preventing type 2 diabetes in people with prediabetes, and there are indications that it offers real health benefits in that group. However, the claim reverses the comparison: the fact that metformin is useful in prediabetes does not automatically mean it works less well in fully developed diabetes. Metformin is also a well-supported first-line treatment for type 2 diabetes. The available studies do not directly compare the two groups in terms of effectiveness, so the claim that it works "considerably better" in prediabetes goes beyond what the evidence supports.
Partly
“The use of metformin lowers blood citrulline levels.”
Navdeep Chandel (Professor of medicine and cell and molecular biology) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
Several human studies do show that metformin is associated with lower blood citrulline levels. A large-scale study of metabolic products in a German population found that citrulline was clearly lower in people with type 2 diabetes who used metformin, and this was confirmed in a seven-year follow-up measurement. A study in people with type 2 diabetes and obesity and a study in Jordanian diabetic patients on metformin report similar findings. Nevertheless, the claim goes slightly further than the evidence allows: one study used a combination of metformin and pioglitazone, meaning the effect cannot be attributed to metformin alone, and a study in non-diabetic African American participants did not focus specifically on citrulline but on broader metabolic changes. The claim is therefore largely supported, but applies most strongly to people with type 2 diabetes, while the evidence for people without diabetes is less clear-cut.
Partly
“Cells in the heart or muscles, for example, can survive for months on glycolysis when the mitochondrial respiratory chain fails, by activating AMPK and inhibiting mTOR.”
Navdeep Chandel (Professor of medicine and cell and molecular biology) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
Research shows that when cellular energy production fails, cells do indeed activate a survival programme that relies on sugar as fuel (glycolysis) and on a protein that monitors the cell's energy balance (AMPK). This has been most clearly demonstrated in human skin cells in the laboratory, where cells died as soon as energy production was blocked if that monitoring protein was absent. In heart and muscle cells, this monitoring protein and another regulatory protein (mTOR) do play an important role under conditions of energy production stress and energy deficiency, but the studies do not support the claim that this persists for months in heart or muscle tissue. Moreover, the role of inhibiting that second regulatory protein in this specific survival programme has not been directly demonstrated: in the skin cells, no change in that regulatory protein was found, while its inhibition in heart cells works primarily through the clearance of cellular waste rather than specifically as a switch to using sugar as fuel.
Partly
“Alpha-ketoglutarate levels decline as we age.”
Navdeep Chandel (Professor of medicine and cell and molecular biology) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
Several review studies note that alpha-ketoglutarate levels in the body decline with age, and one study explicitly states this as an established fact in both animal models and humans. The direction of the claim is therefore correct. However, most of the studies supporting this finding were conducted in animals such as worms, fruit flies and mice, and the evidence in humans remains limited. Moreover, several review studies note that too few studies in humans have been conducted to fully confirm the role of alpha-ketoglutarate in ageing.
Partly
“An elevated level of the inflammatory molecule IL-6 promotes thrombosis and increases susceptibility to cardiovascular disease, such as a heart attack.”
Navdeep Chandel (Professor of medicine and cell and molecular biology) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
IL-6 reliably rises after a high-fat meal and is indeed seen in research as an inflammatory marker associated with cardiovascular disease. The claim that elevated IL-6 also promotes thrombosis and thereby increases the risk of a heart attack goes beyond what the available studies directly demonstrate: those focus on the temporary rise following a meal and the association with inflammatory processes, not on the thrombosis pathway as an established mechanism. The statement thus combines two steps that are each plausible individually, but which as a whole are not substantiated by the available evidence.
Partly
“Vitamin E helps detoxify harmful lipid peroxides in the body.”
Navdeep Chandel (Professor of medicine and cell and molecular biology) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
Several review studies describe vitamin E as an antioxidant that interrupts the chain reaction of fat oxidation (lipid peroxidation) and thereby neutralises harmful peroxides. That is essentially correct. However, the studies do nuance this: vitamin E primarily prevents peroxides from accumulating further, rather than actively "detoxifying" peroxides that have already formed, in the way one would describe a detoxifying enzyme. Moreover, a review study in humans found no demonstrable reduction in exercise-induced lipid peroxidation from additional vitamin E supplements. Most of the evidence for the mechanism of action comes from laboratory and animal research, not from studies that directly examined the effect in humans.
Too early
“An NAD supplement can stimulate liver recovery and regeneration.”
Navdeep Chandel (Professor of medicine and cell and molecular biology) · The Drive, November 2026 · watch the episode ↗︎ · stated with caution
Several mouse studies show that NAD supplementation (via precursors such as nicotinamide, nicotinamide riboside or nicotinamide mononucleotide) promotes liver recovery and regeneration after liver surgery or in alcohol-related liver damage. Laboratory research using liver cells also supports this effect. However, all this research has been conducted in mice or in the laboratory, and the claim implies an effect in humans. Clinical trials in humans for liver regeneration have not yet been found, and human evidence is therefore still lacking.
✓ Holds up
“Taking metformin before a meal keeps blood sugar levels lower.”
Navdeep Chandel (Professor of medicine and cell and molecular biology) · The Drive, November 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with caution
Two randomised controlled studies show that people with type 2 diabetes keep their post-meal blood sugar rise significantly more under control when they take metformin before a meal rather than after. One study involving twenty women confirmed this using a standardised meal test and a continuous glucose monitor. A second study with sixteen participants found the same pattern and linked the improved effect to greater production of a hormone that stimulates insulin release. A review article on the influence of timing on drug efficacy also mentions this as a promising strategy. The claim is therefore well supported for people with type 2 diabetes, although the studies specifically concern the rise in blood sugar after a meal rather than blood sugar levels overall.
Partly
“When mitochondria produce too little hydrogen peroxide, T cells cannot form memory T cells after encountering a pathogen.”
Navdeep Chandel (Professor of medicine and cell and molecular biology) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
Research shows that hydrogen peroxide plays an important role in the formation of memory T cells. One laboratory study demonstrates that scavenging hydrogen peroxide (via an enzyme that breaks it down) blocks the transition to a specific type of memory T cell, while at the same time actually increasing other memory markers. The claim states that too little hydrogen peroxide completely prevents memory formation, but the research paints a more nuanced picture: some memory processes are actually stimulated while others are inhibited. Moreover, this has only been studied in laboratory conditions using human cells, not in humans themselves, and the second study concerns other signalling molecules and does not directly test the claim.
Partly
“Red light therapy has proven effective for skin rejuvenation in clinical research.”
Navdeep Chandel (Professor of medicine and cell and molecular biology) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
There is serious evidence from clinical studies that red light therapy can improve wrinkles and skin texture, so the general direction of the claim is correct. However, the studies are limited in size, not all of them included a control group, and the most rigorously designed study found that red light without a photosensitiser had no effect on photodamaged skin. Saying that it has "proven effective" goes beyond what the current evidence supports: the results are modest and the research is not yet broad enough to justify such a definitive conclusion.
Partly
“In mice, administering metformin significantly reduces clonal haematopoiesis through inhibition of mitochondrial complex 1.”
Navdeep Chandel (Professor of medicine and cell and molecular biology) · The Drive, November 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
Two studies published in Nature (2025) indeed show that metformin reduces the growth advantages of blood stem cells with a specific genetic abnormality in mice, and that an effect on the energy-producing structures in cells plays a role in this. The claim is therefore correct for those specific mouse experiments. However, the research focuses exclusively on stem cells with that one genetic abnormality, whereas the claim refers to a broader form of cell growth in the blood. Furthermore, the same studies also demonstrated effects in human stem cells and in people taking metformin in a large British health database, meaning the findings extend beyond mice alone, but evidence from direct research in patients is still lacking.
Partly
“Between 70 and 80 percent of mitochondrial protein capacity must be lost before a cell or tissue shows noticeable dysfunction.”
Navdeep Chandel (Professor of medicine and cell and molecular biology) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
Research in people with diseases affecting the energy-producing structures in their cells does indeed show that a threshold effect exists: measurable problems only arise once a certain proportion of the capacity of those structures has been lost. The studies thus confirm the core of the claim. However, the figure of 70 to 80 percent is not confirmed as a fixed threshold in these studies. For example, one study in patients with a specific hereditary disease of these energy-producing structures shows a sharp threshold at just around 10 percent of healthy genetic material remaining in those structures, which inversely corresponds to a loss of around 90 percent. Moreover, the studies indicate that the threshold varies considerably depending on the cell and tissue type, the type of abnormality, and the energy requirements of the tissue, making a single universal percentage misleading.
✓ Holds up
“Clinical trials on antioxidant supplements show no health benefits and in some cases found worse outcomes for cancer.”
Navdeep Chandel (Professor of medicine and cell and molecular biology) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
Decades of clinical research into antioxidant supplements such as beta-carotene and vitamin E indeed show no health benefits against cancer or cardiovascular disease. What is more, beta-carotene was found to increase the risk of lung cancer in (former) smokers, which confirms the worse outcomes mentioned in your claim. The claim therefore accurately describes what the trials have shown. The only proven exception is a specific formula for advanced macular degeneration, but that falls outside the broad claim about cancer.

Peter Attia, M.D.

American physician and podcast host specializing in longevity and metabolic health

Partly
“Drinking seven alcoholic drinks in one evening is more harmful to the liver than one drink per evening over seven consecutive evenings.”
Peter Attia, M.D. (American physician and podcast host specializing in longevity and metabolic health) · The Drive, August 2026 · stated with caution
It is true that drinking patterns matter: heavy drinking in a single evening causes acute damage and increases the risk of alcoholic hepatitis. However, the liver research does not point in one direction: a large Danish cohort study found that daily drinking actually raised the risk of cirrhosis more than drinking on just a few days per week. The comparison is therefore less clear-cut for the liver than the claim suggests.
✓ Holds up
“Before the menopause, oestrogen offers relative protection against the build-up of visceral fat and fat in the liver.”
Peter Attia, M.D. (American physician and podcast host specializing in longevity and metabolic health) · The Drive, August 2026 · watch the episode ↗︎ · stated with confidence
Correct. Before menopause, oestrogen directs fat more towards the hips and thighs and less towards the abdominal cavity and the liver. After menopause that shifts, and with it the risk of fatty liver disease rises. It is one of the most striking metabolic differences between men and women.
✓ Holds up
“In the presence of existing cardiometabolic risk factors and liver steatosis, moderate alcohol consumption increases liver-specific mortality by a factor of 15.”
Peter Attia, M.D. (American physician and podcast host specializing in longevity and metabolic health) · The Drive, August 2026 · watch the episode ↗︎ · stated with confidence
Correct, and it is an important warning. Anyone who already has a fatty liver combined with obesity, high blood pressure, or diabetes faces a far greater risk of serious liver damage from moderate drinking than someone without that combination. The two factors reinforce each other, meaning moderate drinking is by no means safe in that situation.
✓ Holds up
“Consumption of fructose and sucrose leads to a doubling of de novo lipogenesis in the liver compared to glucose.”
Peter Attia, M.D. (American physician and podcast host specializing in longevity and metabolic health) · The Drive, August 2026 · watch the episode ↗︎ · stated with confidence
True, and this is one of the most thoroughly studied differences between sugars. Fructose is processed almost entirely in the liver, where it strongly stimulates fat production, far more so than glucose. This is precisely why soft drinks and fruit juice place a greater burden on the liver than the same number of calories from starch.
Partly
“An increase in muscle mass leads to a more than fourfold higher chance of recovery from metabolic fatty liver disease (MASLD).”
Peter Attia, M.D. (American physician and podcast host specializing in longevity and metabolic health) · The Drive, August 2026 · watch the episode ↗︎ · stated with confidence
This comes from studies in which participants were followed for several years, and those studies did indeed show that people who gained muscle mass were more likely to recover from their fatty liver disease. However, observational research cannot separate cause and effect: people who exercise more usually also change their diet, weight, and alcohol consumption. That muscle mass plays a role is plausible; a fourfold increase in odds is a figure drawn from a single study.
✓ Holds up
“Fatty liver disease is estimated to affect more than 38% of the adult world population.”
Peter Attia, M.D. (American physician and podcast host specializing in longevity and metabolic health) · The Drive, August 2026 · watch the episode ↗︎ · stated with confidence
True, and that figure has been revised sharply upward in recent years. Systematic reviews consistently find that around thirty to forty percent of adults worldwide are affected, making fatty liver disease the most common liver condition. The vast majority of those people are unaware of it, as it causes no symptoms for a long time.

Jeff Cavaliere

physiotherapist and strength trainer

Partly
“Diet determines body fat percentage.”
Jeff Cavaliere (physiotherapist and strength trainer) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
Diet plays a role in body fat, but does not determine it on its own. Research shows that the ratio of fat to carbohydrates makes little difference to weight in the long term as long as total calorie intake remains the same, and that exercise is at least as important a lever as diet. Moreover, hormones and body fat reinforce each other with age in an interplay that is independent of diet. The claim therefore overlooks the role of other factors such as exercise, hormones and genetics.
Partly
“To stimulate high-threshold muscle fibres to grow, a set must be performed close to technical muscular failure.”
Jeff Cavaliere (physiotherapist and strength and conditioning coach) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
Research in humans shows that high-threshold muscle fibres are recruited as an effort becomes more intense or fatigue sets in. One review study reports that light loads performed to muscular failure lead to the recruitment of this type of muscle fibre, comparable to what happens with heavy loads. The claim is therefore correct in its direction, but it has not yet been established whether training to muscular failure actually leads to greater muscle growth than stopping before that point. Moreover, the evidence for light loads taken to failure applies mainly to untrained individuals, and it is unclear whether the same holds for well-trained individuals.
Partly
“During strength training, athletes often misjudge by 1 to 3 repetitions how close they actually are to muscle failure”
Jeff Cavaliere (physiotherapist and strength and conditioning coach) · The Drive, November 2026 · watch the episode ↗︎ · stated with caution
Several studies in trained individuals show that athletes do indeed struggle during strength training to estimate how many repetitions they have left before their muscles give out, and that they generally underestimate this. One study found an average underestimation of around 2 repetitions, but another study in trained men and women on the bench press found high accuracy with only a small tendency to underestimate. The studies also show that the margin of error depends on factors such as the weight used (lighter weights lead to a larger error), the point in the exercise, and how close to exhaustion one already is. The figure of "1 to 3 repetitions" as a fixed margin therefore does not hold in all situations: with heavy weights or advanced fatigue, athletes are considerably more accurate, while the error can be larger with lighter weights. Furthermore, one of the studies cited, identifiable by a unique registration number in a scientific database, has been retracted by its publishers and is therefore unreliable as evidence. → How accurately do athletes estimate their limit during strength training?
Partly
“Training sets closer to muscle failure can reduce total training volume, which decreases joint wear while preserving muscle growth”
Jeff Cavaliere (physiotherapist and strength and conditioning coach) · The Drive, November 2026 · watch the episode ↗︎ · stated with confidence
Research in humans shows that training closer to the point where you can no longer complete a repetition yields comparable muscle growth to training to complete failure, which supports the first part of the claim. A large review study combining multiple studies, and a direct study in trained adults, do indeed confirm that comparable muscle growth can be achieved with somewhat fewer repetitions, and therefore potentially less total training volume. However, none of the research examined measures joint wear or joint load: whether athletes thereby sustain less joint damage has not been investigated in these studies. The claim therefore goes beyond what the evidence shows. → Does training with fewer sets work if you train to muscle failure?
✗ Does not hold up
“Keeping four or more reps in reserve during strength training yields barely any effective muscle growth and counts as useless training volume”
Jeff Cavaliere (physiotherapist and strength coach) · The Drive, November 2026 · watch the episode ↗︎ · stated with caution
Multiple studies in humans, including one that pools and analyses the results of many earlier studies, show that training with reps in reserve does produce muscle growth. A comprehensive review of existing research found no difference in muscle growth between training to the point where you can no longer perform a rep and training with reps still left. A direct study in trained adults who trained with 4 to 6 reps in reserve found comparable muscle growth to the group that trained close to failure, as long as the total training volume was equivalent. A statistical analysis of multiple studies simultaneously does suggest that muscle growth increases the closer you train to your limit, but that analysis also emphasises that the exact relationship remains unclear. The claim that keeping 4 or more reps in reserve yields 'barely any effective muscle growth' and is 'useless' is therefore not supported by this research. → Do you need to train to muscle failure for maximum muscle growth?

Siddhartha Mukherjee

Oncologist, biologist and author

✓ Holds up
“Bowel cancer is becoming increasingly common among young people”
Siddhartha Mukherjee (Oncologist, biologist and author) · The Drive, October 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
Several large studies confirm that bowel cancer is clearly occurring more often among young people. American research shows that the number of new cases among adults aged 20 to 49 is rising by around 3% per year, while it is actually falling among older people. An international study using data from Australia, Canada, England and the United States shows that people born in the 1990s develop bowel cancer before the age of fifty at least four times as often as people born in the 1960s. A global review article and research from Hawaii also confirm this rising trend among younger age groups, and this pattern is visible in both men and women and across multiple countries.
Partly
“CAR T-cell therapy can permanently cure certain types of leukaemia and lymphoma”
Siddhartha Mukherjee (Oncologist, biologist and author) · The Drive, October 2026 · watch the episode ↗︎ · stated with confidence
Research in humans shows that CAR T-cell therapy can indeed bring about long-lasting periods free of disease in certain types of lymphoma and leukaemia. In one study of patients with B-cell lymphoma, approximately a third to a half remained disease-free after ten years, and after 5.4 years no further relapses occurred. In acute lymphoblastic leukaemia, a large meta-analysis shows a two-year survival rate of 55% for CAR T-cell therapy, which is better than the comparator treatment. However, the claim that the therapy can "cure" goes a step further than what the evidence strictly proves: researchers cautiously describe it as "probably curative for a subset of patients", but definitive cure has not yet been formally demonstrated. Moreover, the effect does not apply to all types of leukaemia and lymphoma, and the therapy has so far been proven effective in specific, heavily pre-treated patient groups with B-cell conditions.
✓ Holds up
“Obesity is associated with an increased risk of uterine cancer (endometrial cancer).”
Siddhartha Mukherjee (Oncologist, biologist and author) · The Drive, October 2026 · watch the episode ↗︎ · stated with confidence
The link between excess weight and uterine cancer is well established: excess weight has been shown to cause an increased cancer risk at at least thirteen sites, and uterine cancer is among the types with the strongest evidence. It is therefore one of the better-documented associations within the broader body of research into excess weight and cancer.
Partly
“The hereditary risk of breast cancer in many women is influenced by a combination of possibly hundreds of genes, each with a small effect.”
Siddhartha Mukherjee (Oncologist, biologist and author) · The Drive, October 2026 · watch the episode ↗︎ · stated with caution
Hereditary breast cancer is well documented, and the role of known genes such as BRCA1 and BRCA2 is beyond dispute. Research into multiple genes each with a small effect also exists, but our sources focus primarily on the major, well-known mutations and not on the polygenic model involving possibly hundreds of small effects. The direction of the claim is scientifically plausible, but the specific figure of "hundreds of genes" and the assertion that this is the determining factor for "many women" cannot be substantiated on the basis of the available evidence.
✓ Holds up
“Obesity is a risk factor for certain types of cancer, including uterine cancer.”
Siddhartha Mukherjee (Oncologist, biologist and author) · The Drive, October 2026 · watch the episode ↗︎ · stated with confidence
Overweight and obesity are well-established causes of an increased cancer risk for at least 13 types of cancer. Uterine cancer is among those with the strongest associations, along with colorectal cancer, liver cancer, and breast cancer after the menopause. The evidence comes from large observational studies and genetic analyses, and is therefore solid enough to identify obesity as a genuine risk factor rather than merely a correlation.

Michael Davidson

Cardiologist, lipidologist, professor at the University of Chicago and CEO of NewAmsterdam Pharma

Partly
“DHA crosses the blood-brain barrier primarily in the form of lysoPC-DHA via the MFSD2A transporter.”
Michael Davidson (Cardiologist, lipidologist, professor at the University of Chicago and CEO of NewAmsterdam Pharma) · The Drive, September 2026 · watch the episode ↗︎ · stated with confidence
Research, including an influential mouse study published in Nature, shows that MFSD2A is an important transporter for DHA in the form of lysoPC (lysoPC-DHA) across the blood-brain barrier. The finding that lysoPC-DHA reaches the brain via MFSD2A is therefore well supported. However, the word "primarily" does not hold up without qualification: a review study shows that the free (non-esterified) form of DHA in the blood contributes the largest share to the supply of DHA to the brain in absolute terms, with other transport proteins as key players. The claim thus presents as the main route something that the research identifies as an important but not uncontestedly dominant route.
Partly
“Maintaining an LDL cholesterol level below 80 mg/dL throughout life prevents the development of cardiovascular disease.”
Michael Davidson (Cardiologist, lipidologist, professor at the University of Chicago and CEO of NewAmsterdam Pharma) · The Drive, September 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
Several large analyses of hundreds of studies and hundreds of thousands of participants show that a lower LDL level over a longer period clearly reduces the risk of cardiovascular disease, and that this effect grows the longer the exposure lasts. The idea that a low LDL level can delay or prevent the development of cardiovascular disease is also supported by the research. However, the threshold of 80 mg/dL is not mentioned in the study summaries as a specific target figure: they consistently refer to cumulative exposure over time and the principle that lower is better, not to a fixed threshold that guarantees complete prevention. Moreover, the studies speak of a reduction in risk, not of complete prevention. → How early should you start lowering your LDL cholesterol?

Katie Gray

Physician-scientist (M.D., Ph.D.) and specialist in obstetrics and fetal medicine

✓ Holds up
“Having pre-eclampsia doubles or substantially increases the long-term risk of chronic hypertension and cardiovascular disease later in life.”
Katie Gray (Physician-scientist (M.D., Ph.D.) and specialist in obstetrics and fetal medicine) · The Drive, October 2026 · watch the episode ↗︎ · stated with confidence
Several large studies following women over extended periods consistently show that pre-eclampsia substantially raises the risk of chronic high blood pressure and cardiovascular disease later in life. A meta-analysis of nearly 3.5 million women found that the risk of high blood pressure is almost four times greater and the risk of cardiac ischaemia more than twice as great. Another meta-analysis reported a fourfold increased risk of heart failure and a twofold increased risk of coronary artery disease, stroke, and death from cardiac causes. The claim that the risk 'doubles or is substantially increased' therefore aligns well with the available evidence in humans.
Partly
“About 50 percent of women with gestational diabetes develop type 2 diabetes later in life.”
Katie Gray (Physician-scientist (M.D., Ph.D.) and specialist in obstetrics and fetal medicine) · The Drive, October 2026 · watch the episode ↗︎ · stated with confidence
Gestational diabetes does demonstrably increase the risk of type 2 diabetes later in life, and that link is well enough established to be taken seriously. However, the specific figure of 'about 50 percent' cannot be substantiated on the basis of available research. The direction of the claim is correct; only that precise percentage has not been confirmed.

From the episodes, no speaker named

✓ Holds up
“In a large proportion of patients with a mildly elevated TSH value, this value returns to normal spontaneously on a repeat measurement.”
The Drive, September 2026 · watch the episode ↗︎ · stated with caution
Several studies in humans support this statement. In a large study among people aged 65 and over, the TSH value returned to normal in 60.8% of participants at a first repeat measurement, and even after confirmation by a second elevated measurement, the value normalised in a further 39.9%. A prospective study among women with mildly elevated TSH showed that in approximately 23% of cases the value returned to normal on its own over a period of five years. A long-term follow-up study, in which a large group of people was followed over an extended period, showed that 40% of participants with subclinical hypothyroidism had a normal TSH value after an average of ten years. These findings apply in particular to people with a mild TSH elevation and without certain risk factors.
Partly
“Intensive lowering of systolic blood pressure to below 120 mmHg reduces cardiovascular mortality by approximately 25% and overall mortality by 27% compared to a target of below 140 mmHg.”
The Drive, September 2026 · watch the episode ↗︎ · stated with confidence
Research does support the finding that intensive blood pressure treatment reduces the risk of cardiovascular disease and mortality. One study even mentions a halving of cardiovascular mortality in people who use medication. However, the precise percentages cited in the claim, a reduction of 25% in cardiovascular mortality and 27% in overall mortality with a target of below 120 versus below 140 mmHg, cannot be substantiated based on the available evidence. Moreover, research indicates that overly intensive treatment carries a real risk of dangerously low blood pressure, a caveat the claim omits entirely.
Partly
“An excess of calories causes fat to accumulate around the organs and insulin sensitivity to deteriorate.”
The Drive, October 2026 · watch the episode ↗︎ · stated with confidence
A caloric surplus contributes to visceral fat accumulation and deteriorating insulin sensitivity, but the evidence shows that the causes are broader. Dietary patterns, meal timing and alcohol consumption all affect insulin sensitivity independently of total caloric intake. The claim therefore points to a real factor, but presents it as the sole cause, whereas the evidence paints a more complex picture.
✗ Does not hold up
“Fasting for about three days stimulates autophagy significantly more than exercise does.”
The Drive, October 2026 · watch the episode ↗︎ · stated with caution
Both fasting and exercise can activate autophagy, but a direct comparison between "three days of fasting" and exercise has not been established. The threshold in hours or days for measurably increased autophagy in humans is not known, and reliable measurement of autophagy outside a laboratory setting is not possible. The claim proposes a quantitative hierarchy that current research does not support.
Partly
“When metabolic health deteriorates, the risk of all other chronic diseases increases.”
The Drive, October 2026 · watch the episode ↗︎ · stated with confidence
Metabolic problems such as fatty liver disease, chronic inflammation and a weakened immune system are indeed associated with an increased risk of several serious diseases, and that link is well documented for a considerable number of conditions. However, the claim that poor metabolic health increases the risk of ALL other chronic diseases goes beyond what the available research shows: for each individual condition, that link has not been proven, and for some cancers the association remains presumed rather than established as causal. The direction of the claim is correct, but the phrasing "all other chronic diseases" is too broad and too categorical.
Partly
“Sleeping fewer than 5 hours or more than 10 hours a night is linked to an up to 40% increased risk of developing hypertension.”
The Drive, September 2026 · watch the episode ↗︎ · stated with confidence
Research does indeed show that chronically short sleep is associated with an increased risk of high blood pressure, and this link has been found consistently in large populations. Sleeping too long is also associated with cardiovascular risks in population studies. However, the precise figure of 'up to 40% increased risk' and the exact upper threshold of 10 hours cannot be firmly established on the basis of the available research, and a fully proven causal relationship has yet to be demonstrated.
Newsletter

Stay in the loop

Every Thursday, the most important longevity research in your inbox, focused on what you follow.